"hypertension comorbidities" trang 5 - tải miễn phí từ tailieunhanh
A modified risk score in one-year survival rate assessment of group 1 pulmonary arterial hypertension

A modified risk score in one-year survival rate assessment of group 1 pulmonary arterial hypertension
10    29    1
Genome-wide association study identifies loci and candidate genes for non-idiopathic pulmonary hypertension in Eastern Chinese Han population

Genome-wide association study identifies loci and candidate genes for non-idiopathic pulmonary hypertension in Eastern Chinese Han population
8    43    1
High-sensitive Troponin T increase after exercise in patients with pulmonary arterial hypertension

High-sensitive Troponin T increase after exercise in patients with pulmonary arterial hypertension
7    34    1
Psychometric performance of the CAMPHOR and SF-36 in pulmonary hypertension

Psychometric performance of the CAMPHOR and SF-36 in pulmonary hypertension
8    20    1
Epidemiology and long-term survival of pulmonary arterial hypertension in the Czech Republic: A retrospective analysis of a nationwide registry

Epidemiology and long-term survival of pulmonary arterial hypertension in the Czech Republic: A retrospective analysis of a nationwide registry
9    35    1
Impairment of pulmonary vascular reserve and right ventricular systolic reserve in pulmonary arterial hypertension

Impairment of pulmonary vascular reserve and right ventricular systolic reserve in pulmonary arterial hypertension
10    52    1
High plasma adiponectin is associated with increased pulmonary blood flow and reduced right ventricular function in patients with pulmonary hypertension

High plasma adiponectin is associated with increased pulmonary blood flow and reduced right ventricular function in patients with pulmonary hypertension
9    36    1
Evidence synthesis in pulmonary arterial hypertension: A systematic review and critical appraisal

Evidence synthesis in pulmonary arterial hypertension: A systematic review and critical appraisal
17    48    1
Serum uric acid is associated with disease severity and may predict clinical outcome in patients of pulmonary arterial hypertension secondary to connective tissue disease in Chinese: A single-center retrospective study

Serum uric acid is associated with disease severity and may predict clinical outcome in patients of pulmonary arterial hypertension secondary to connective tissue disease in Chinese: A single-center retrospective study
9    31    1
Clinical evaluation of pulmonary hypertension using patient‑reported outcomes: A cross‑sectional study

Clinical evaluation of pulmonary hypertension using patient‑reported outcomes: A cross‑sectional study
9    22    1
Bmi-1 alleviates adventitial fbroblast senescence by eliminating ROS in pulmonary hypertension

Bmi-1 alleviates adventitial fbroblast senescence by eliminating ROS in pulmonary hypertension
10    31    1
The efects of ductal size on the severity of pulmonary hypertension in children with patent ductus arteriosus (PDA): A multi-center study

The efects of ductal size on the severity of pulmonary hypertension in children with patent ductus arteriosus (PDA): A multi-center study
8    38    1
NTP42, a novel antagonist of the thromboxane receptor, attenuates experimentally induced pulmonary arterial hypertension

NTP42, a novel antagonist of the thromboxane receptor, attenuates experimentally induced pulmonary arterial hypertension
16    31    1
Clinical characteristics and survival of Chinese patients diagnosed with pulmonary arterial hypertension who carry BMPR2 or EIF2KAK4 variants

Clinical characteristics and survival of Chinese patients diagnosed with pulmonary arterial hypertension who carry BMPR2 or EIF2KAK4 variants
8    36    1
Supervised pulmonary hypertension exercise rehabilitation (SPHERe): Study protocol for a multi-centre randomised controlled trial

Supervised pulmonary hypertension exercise rehabilitation (SPHERe): Study protocol for a multi-centre randomised controlled trial
14    37    1
Changes in REVEAL risk score in patients with pulmonary arterial hypertension treated with macitentan in clinical practice: Results from the PRACMA study

Changes in REVEAL risk score in patients with pulmonary arterial hypertension treated with macitentan in clinical practice: Results from the PRACMA study
10    47    1
Temporal echocardiographic assessment of pulmonary hypertension in idiopathic pulmonary fibrosis patients treated with nintedanib with or without oxygen therapy

Temporal echocardiographic assessment of pulmonary hypertension in idiopathic pulmonary fibrosis patients treated with nintedanib with or without oxygen therapy
9    35    1
Healthcare utilization, medical expenditure, and mortality in Korean patients with pulmonary hypertension

Healthcare utilization, medical expenditure, and mortality in Korean patients with pulmonary hypertension
11    54    1
Novel homozygous BMP9 nonsense mutation causes pulmonary arterial hypertension: A case report

Novel homozygous BMP9 nonsense mutation causes pulmonary arterial hypertension: A case report
4    23    1
Pulmonary artery involvement in Takayasu’s arteritis: Diagnosis before pulmonary hypertension

Pulmonary artery involvement in Takayasu’s arteritis: Diagnosis before pulmonary hypertension
9    48    1